Masaya Takahashi1
1Guerbet Japan, Japan
Synopsis
Purpose: Pulmonary function tests (PFTs) are
global measurements where contributions from regions of normal and varying
degrees of alteration in function are combined. Non-uniform disruption of
lung architecture is usually assessed by high-resolution computed tomography
(CT), which incurs radiation exposure and yields only static anatomical data.
Our purpose was to evaluate and define the applications of functional thoracic
MRI to bridge anatomical and functional assessment of the lung in regional
parenchymal diseases.
Target audiences
Researchers
and clinicians interested in regional anatomical and functional imaging of the
lung. Outcome/Objectives
Learning
the feasibility of proton MRI to assess the anatomy and functions in the lung,
one of the most difficult organs, will motivate to develop further applications
with exploiting the features of MRI even in the other organs.Purpose
Pulmonary function tests (PFTs) are
global measurements where contributions from regions of normal and varying
degrees of alteration in function are combined [1]. Non-uniform disruption of
lung architecture is usually assessed by high-resolution computed tomography
(CT), which incurs radiation exposure and yields only static anatomical data.
Our purpose was to evaluate and define the applications of functional thoracic
MRI to bridge anatomical and functional assessment of the lung in regional
parenchymal diseases. Methods
The utility of ultra-short TE (UTE)
imaging in conjunction with a projection acquisition of the free induction
decay could reduce the TE to less than 100 µsec and provide a more inherent MR
signal from the lung parenchyma which is usually invisible due to its short T2*
in conventional MRI methods. With this method at 3T, we first measured signal
intensity (SI) and T2* of the normal murine lung parenchyma at different
positive end-expiratory pressures (PEEPs). Adjustment of PEEP levels enables
the generation of a pseudo-pathological condition in which changes in intrinsic
interstitial tissue density can be introduced in a controlled fashion [2]. Subsequently,
we measured the SI and T2* in the emphysematous lungs, a real pathology, using
a transgenic mouse model [3]. We hypothesized that the capability of the method
to acquire inherent MR signal of the lung parenchyma should allow us to assess
changes in SI due to inhalation of molecular oxygen or intravenous injection of
gadolinium (Gd). Using an animal model of pulmonary embolism (PE), we tested
the feasibility of a UTE imaging for assessment of regional pulmonary
ventilation/perfusion that are essential for the evaluation of a variety of
lung diseases [4]. These applications were expanded to clinical study to
investigate the feasibility and utility of the methods in normal subjects and
patients in several lung diseases with compared to the results in PFT [5].Results
When the lung inflated, the tissue density in the lung
was reduced due to enlargement of alveolar airspace, in proportion to
reciprocal of increase of lung volume, resulted in reduction of the SI and T2*
(Fig. 1). The changing rates in our measured SIs and T2* were larger
than that in the estimated alveolar airspace, indicating that the UTE imaging
would have the potential to sensitively assess interstitial tissues’
density/volume for the detection and characterization of non-uniform disruption
of lung architecture. Further, the emphysematous lung parenchyma had reduced SI
and the T2* of the lung parenchyma (0.70 ± 0.07 msec) compared with that in the
wild type (1.16 ± 0.15 msec, Fig. 2), which closely related to the
parenchymal tissue density (alveolar airspace). Regarding the ventilation
imaging by inhalation of 100% oxygen, the T1 of the lung parenchyma was reduced
by ~24% (air: 1370 ± 159 ms v.s. 100% oxygen: 1049 ± 93 ms) and led increased
SI. The normal parenchymal SI increased 580 ± 172 % right after Gd-injection,
and then gradually decreased over time. In the animals that had regional PE,
several regions showed perfusion deficit (red allow, Fig. 3) in which
the increase of SI was lower up to 15 min after Gd injection than that in the
normal parenchyma. By contrast, the abnormal regions showed almost identical
changes in SI with the surrounding normal parenchyma in response to oxygen
inhalation, indicating ventilation/perfusion mismatch. Discussion
In the
sequence, the readout starts immediately after the RF system is switched from
transmit to receive so that the MR signal could be acquired before it decays
even in the lung parenchyma. The signal is acquired using a center-out sampling
scheme, which corresponds to sampling the FID. A minimal duration of the
sampling window is archived using radial sampling where the center of k-space
is heavily oversampled. These have contributed also to reduce motion artifacts
on the UTE images, providing accurate measure of both SI and T2* by reduced
responding to inflation of the lung. Further, the high correlations between the
SI and T2* and the lung volume suggest that these MRI parameters are sensitive
to the tissue density in the lung parenchyma. We postulate that the amount of
signal would reflect interstitial tissue density (sum of blood volume, elastic
fibers in the alveolar walls and around the blood vessels, bronchi and
surfactant) although short T2* effect still reduces the MRI signal, particular
in emphysema. UTE imaging was a great advantage in generation of the calculated
images (e.g. ventilation/perfusion maps) and assessment of regional parenchymal
functions since the currently presented ventilation/perfusion MR imaging
methods are particularly sensitive to motion artifact and position mismatch.Conclusion
These
methods by UTE imaging have the potential to significantly broaden the scope of
state-of-the-art diagnostic imaging capabilities without incurring the risks of
radiation exposure. The method is feasible in standard clinical MRI systems.
To challenge MRI of the lung, one of the most
difficult organs, will advantage you to level up your skills and understandings
of MRI and, thus, can help you to solve many issues you may face in the future
even in any kind of MRI studies.Acknowledgements
No acknowledgement found.References
1. J.L. Clausen.
The diagnosis of emphysema, chronic bronchitis, and asthma. Clin Chest Med
11:405 (1990).
2. O. Togao, R.
Tsuji, Y. Ohno, et al. Ultra-short echo time (UTE) MRI of the lung: Assessment
of tissue density in the lung parenchyma. MRM 64: 1491 (2010)
3. M. Takahashi,
O. Togao, M. Obara, et al. Ultra-short echo time (UTE) MR imaging of the lung:
Comparison between normal and emphysematous lungs in mutant mice. JMRI 32:326
(2010)
4. O. Togao, Y.
Ohno, I. Dimitrov, et al. Ventilation/Perfusion imaging of the lung using
ultra-short echo time (UTE) MRI in an animal model of pulmonary embolism. JMRI
34:539 (2011)
5. Y. Ohno, H.
Koyama, K. Matsumoto, et al. T2* Measurements of 3-T MRI with ultra-short TE:
Capabilities of pulmonary functional assessment and clinical stage
classification in smokers. AJR 197:w279 (2011)